| |
| |
|
| Insider
Information: |
Ramsay David A |
| Relationship: |
Director |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,587,962 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,152,793 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,587,962 |
|
|
| Total
Value |
$26,152,793 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
0
|
|
Stock
price went up :
|
46
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.8
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
VP and Chief Financial... |
2015-02-06 |
364,320 |
|
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
2,223,642 |
2012-05-09 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2022-08-22 |
0 |
2020-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-10 |
4 |
B |
$1.04 |
$36,365 |
D/D |
35,000 |
1,411,142 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2015-02-06 |
4 |
D |
$13.87 |
$36,894 |
D/D |
(2,660) |
364,320 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-08-18 |
4 |
B |
$1.18 |
$36,980 |
D/D |
30,736 |
964,090 |
2.39 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2021-12-02 |
4 |
B |
$3.69 |
$37,677 |
D/D |
10,101 |
85,601 |
2.39 |
% |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2021-12-06 |
4 |
B |
$3.75 |
$38,231 |
D/D |
10,000 |
100,000 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Vice President and CFO |
• – – |
2005-01-14 |
4 |
OE |
$0.39 |
$39,000 |
D/D |
100,000 |
376,410 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-12-01 |
4 |
OE |
$2.02 |
$40,517 |
D/D |
20,058 |
343,550 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-08 |
4 |
B |
$1.40 |
$40,571 |
D/D |
29,000 |
1,733,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-23 |
4 |
B |
$1.42 |
$42,660 |
D/D |
30,000 |
1,771,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-26 |
4 |
B |
$1.38 |
$43,052 |
D/D |
31,107 |
1,802,249 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-30 |
4 |
B |
$1.55 |
$44,834 |
D/D |
29,000 |
2,101,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-12-30 |
4 |
B |
$1.30 |
$45,360 |
D/D |
35,000 |
1,501,142 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2008-03-18 |
4 |
B |
$4.50 |
$45,565 |
D/D |
10,000 |
411,410 |
2.74 |
- |
|
| LJPC |
La Jolla Pharmaceutical C... |
Director |
– • – |
2020-08-20 |
4 |
B |
$4.17 |
$50,060 |
D/D |
12,000 |
12,000 |
2.39 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2013-09-16 |
4 |
OE |
$0.39 |
$50,700 |
D/D |
130,000 |
236,735 |
0 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-09-28 |
4 |
B |
$1.29 |
$50,824 |
D/D |
39,552 |
1,003,642 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-06-17 |
4 |
B |
$1.33 |
$52,915 |
D/D |
39,906 |
1,541,048 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-06-27 |
4 |
B |
$2.38 |
$53,774 |
D/D |
22,300 |
86,985 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-08-31 |
4 |
B |
$1.42 |
$56,200 |
D/D |
39,494 |
1,661,374 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-06-22 |
4 |
B |
$1.45 |
$56,355 |
D/D |
39,000 |
1,601,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-09-01 |
4 |
B |
$1.42 |
$56,471 |
D/D |
39,768 |
1,701,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2019-06-17 |
4 |
B |
$2.37 |
$59,550 |
D/D |
25,000 |
48,570 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2021-09-29 |
4 |
B |
$1.28 |
$60,658 |
D/D |
47,500 |
1,051,142 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-19 |
4 |
B |
$1.49 |
$60,834 |
D/D |
40,719 |
1,987,312 |
2.39 |
% |
|
| SVRA |
Savara Inc |
Director |
– • – |
2022-12-22 |
4 |
B |
$1.48 |
$61,127 |
D/D |
41,414 |
2,046,142 |
2.39 |
% |
|
93 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
